Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

576
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
576
Pharmacovigilance01:19

Pharmacovigilance

934
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
934
Allergic Drug Reactions01:27

Allergic Drug Reactions

914
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
914
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

238
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
238
Types of Reports II: Incident or Occurrence Report01:21

Types of Reports II: Incident or Occurrence Report

915
An Incident or Occurrence Report in a healthcare setting is a crucial document used to record any unexpected occurrence that may or may not have affected a patient, employee, or visitor. Such reports are critical to improving patient safety and include all details leading up to and including the event.
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
915
Allergic Reactions02:06

Allergic Reactions

28.1K
Overview
28.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing Ophthalmology Education in Medical Schools: Learned Lessons from Medical-Optometry Interprofessional Education Curriculum.

Medical science educator·2026
Same author

Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part II-Guidelines on Oral and Ocular Treatments.

Allergy·2026
Same author

Factors Associated with Symptomatic Dermographism: Findings from the UCARE PREVALENCE-D Study.

American journal of clinical dermatology·2026
Same author

Switching Long-Term Prophylaxis to Donidalorsen for Hereditary Angioedema: 1-Year OASISplus Results.

Allergy·2026
Same author

An International Delphi Study on Barriers to On-Demand Treatment of Hereditary Angioedema Attacks.

Clinical and translational allergy·2026
Same author

The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria.

Allergy·2026
Same journal

Mast cell activation disorders: mechanisms, comorbidities and look alike.

Expert review of clinical immunology·2026
Same journal

Dendritic cell subsets in alopecia areata: focus on plasmacytoid dendritic cells and Langerhans cells in immune imbalance and therapeutic implications.

Expert review of clinical immunology·2026
Same journal

The role of immunosenescence and chronic medical conditions on the immune response to respiratory syncytial virus in older individuals.

Expert review of clinical immunology·2026
Same journal

Flow cytometry-based basophil and mast cell activation tests for IgE-mediated food and drug allergy: have we crossed the Rubicon?

Expert review of clinical immunology·2026
Same journal

An update on the pharmacotherapy of ANCA-associated vasculitis.

Expert review of clinical immunology·2026
Same journal

Targeting the cytokine storm: new therapies in the treatment of pediatric hemophagocytic lymphohistiocytosis.

Expert review of clinical immunology·2026
See all related articles

Related Experiment Video

Updated: Aug 9, 2025

Screening for Phytoestrogens using a Cell-based Estrogen Receptor β Reporter Assay
06:07

Screening for Phytoestrogens using a Cell-based Estrogen Receptor β Reporter Assay

Published on: June 7, 2020

4.9K

A focused report on progestogen hypersensitivity.

Diti H Patel1, Lauren M Fine1, Jonathan A Bernstein2

  • 1Department of Medical Education, Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale, Florida, USA.

Expert Review of Clinical Immunology
|February 17, 2023
PubMed
Summary
This summary is machine-generated.

Progestogen Hypersensitivity (PH) causes skin reactions and systemic symptoms due to sensitivity to progestogens. Increased awareness and diagnostic tools are crucial for better recognition and management of this condition.

Keywords:
Autoimmune progesterone dermatitisIVFProgesteronedesensitizationprogestinprogestogen hypersensitivityurticaria

More Related Videos

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.2K
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.3K

Related Experiment Videos

Last Updated: Aug 9, 2025

Screening for Phytoestrogens using a Cell-based Estrogen Receptor β Reporter Assay
06:07

Screening for Phytoestrogens using a Cell-based Estrogen Receptor β Reporter Assay

Published on: June 7, 2020

4.9K
Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.2K
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.3K

Area of Science:

  • Immunology
  • Dermatology
  • Endocrinology

Background:

  • Progestogen Hypersensitivity (PH) involves adverse reactions to progestogens, manifesting as skin eruptions and systemic symptoms.
  • Symptoms can be cyclical, correlating with hormone levels, and prevalence is rising due to hormonal therapies.

Purpose of the Study:

  • To highlight the clinical features and diagnostic challenges of Progestogen Hypersensitivity.
  • To emphasize the need for increased medical community awareness and improved diagnostic methods for PH.

Main Methods:

  • Review of clinical presentations and proposed immunological mechanisms of PH.
  • Discussion of diagnostic approaches, including potential for IgE-specific ELISA tests.
  • Exploration of treatment strategies, focusing on ovulation suppression and desensitization.

Main Results:

  • PH presents with diverse symptoms like erythema multiforme, eczema, urticaria, angioedema, asthma, and anaphylaxis.
  • Current understanding and clinical recognition of PH remain limited despite increasing prevalence.
  • Accurate diagnostic tests, like ELISA for progesterone IgE, are needed for better disease identification.

Conclusions:

  • Physicians across specialties must be educated to diagnose and manage PH or refer patients appropriately.
  • Enhanced understanding of PH pathophysiology and improved diagnostics are key to better patient outcomes.
  • Early recognition and management are essential for controlling symptoms associated with progestogen sensitivity.